首页> 外文OA文献 >PARAGON II – A single arm multicentre phase II study of neoadjuvant therapy using irinotecan bead in patients with resectable liver metastases from colorectal cancer

【2h】

PARAGON II – A single arm multicentre phase II study of neoadjuvant therapy using irinotecan bead in patients with resectable liver metastases from colorectal cancer

机译：PARAGON II –使用伊立替康微珠对结直肠癌可切除的肝转移患者进行新辅助治疗的单臂多中心II期研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jones R.P.; Malik H.Z.; Fenwick S.W.; Terlizzo M.; OGrady E.; Stremitzer S.; Gruenberger T.; Rees M.; Plant G.; Figueras J.; Albiol M.; Adam R.; Awad S.; Poston G.J.;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. PARAGON II - A single arm multicentre phase II study of neoadjuvant therapy using irinotecan bead in patients with resectable liver metastases from colorectal cancer [J] . Jones R. P., Malik H. Z., Fenwick S. W., European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology . 2016,第12期

机译：PARAGON II-使用伊立替康微珠对结直肠癌可切除的肝转移患者进行新辅助治疗的单臂多中心II期研究
2. Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases. [J] . Ychou M, Kramar A, Mitry E, Cancer chemotherapy and pharmacology. . 2008,第2期

机译：氟尿嘧啶/亚叶酸钙，伊立替康和奥沙利铂（FOLFIRINOX）的三联疗法：一项患有不可切除肝转移的结直肠癌患者的II期研究。
3. Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases [J] . M. Ychou, F. Viret, A. Kramar, Cancer Chemotherapy and Pharmacology . 2008,第2期

机译：氟尿嘧啶/亚叶酸钙，伊立替康和奥沙利铂（FOLFIRINOX）的三联疗法：II期研究在无法切除肝转移的大肠癌患者中进行
4. Electrocheiiiotherapy of Colorectal Liver Metastases-Trial Update [C] . I. Edhemovic, E. Brecelj, A. Ivanecz World Congress on Electroporation and Pulsed Electric Fields in Biology, Medicine and Food Environmental Technologies . 2016

机译：结直肠肝转移的电杂化 - 试验更新
5. Cost-effectiveness of imaging and surgery in patients with colorectal cancer liver metastases. [D] . Gazelle, Guy Scott. 1999

机译：大肠癌肝转移患者影像和手术的成本效益。
6. Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial [O] . Erik Skof, Martina Rebersek, Zvezdana Hlebanja, 2009

机译：卡培他滨加伊立替康（XELIRI方案）与5-FU / LV加伊立替康（FOLFIRI方案）比较用于新辅助治疗转移性结直肠癌不可切除的仅肝转移的患者：一项随机的前瞻性II期临床研究
7. 03:18 PM Abstract No. 104 Irinotecan drug-eluting beads chemoembolization (DEBIRI) plus mFolfox6 as front-line treatment in patients with non resectable liver dominant metastases of colorectal cancer (FFCD 1201 phase II trial): result of single-arm, open-label phase II study [O] . O. Pellerin, S. Pernot, V. Vidal, 2019

机译：03:18 PM摘要104 Irinotecan药物洗脱珠子化疗（Debiri）加上MFOLFOX6作为结直肠癌不可切除肝脏常量转移患者的前线治疗（FFCD 1201期试验）：单臂，开放的结果-Label期II研究

PARAGON II – A single arm multicentre phase II study of neoadjuvant therapy using irinotecan bead in patients with resectable liver metastases from colorectal cancer

著录项

引文网络

相似文献

相关主题

期刊订阅